Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models

By  

Oncology Reports, Vol. 32, Iss. 6, 2014-01 ,pp. : 2319-2326

Spandidos Publications

Access to resources Recommend Favorite

Adoptively transferred ex vivo expanded -T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer

By Beck Benjamin  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 135-144

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of AuroraB suppresses osteosarcoma cell migration and invasion

By Zhu Xiao Ping   Liu Zhi Li   Peng Ai Fen   Zhou Yun Fei   Long Xin Hua   Luo Qing Feng   Huang Shan Hu   Shu Yong  

Experimental and Therapeutic Medicine, Vol. 7, Iss. 3, 2014-03 ,pp. : 560-564

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of Aurora-B function increases formation of multinucleated cells in p53 gene deficient cells and enhances anti-tumor effect of temozolomide in human glioma cells

By Tsuno Takaya   Natsume Atsushi   Katsumata Shun   Mizuno Masaaki   Fujita Mitsugu   Osawa Hirokatsu   Nakahara Norimoto   Wakabayashi Toshihiko   Satoh Yu-ichiro   Inagaki Masaki   Yoshida Jun  

Journal of Neuro-Oncology, Vol. 83, Iss. 3, 2007-07 ,pp. : 249-258

Springer Publishing Company

Access to resources Recommend Favorite

Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinase

By Palani Santhosh   Patel Mayankbhai   Huck Jessica   Zhang Mengkun   Balani Suresh   Yang Johnny   Chen Susan   Mettetal Jerome   Manfredi Mark   Shyu Wen   Ecsedy Jeffrey   Chakravarty Arijit  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1255-1264

Springer Publishing Company

Access to resources Recommend Favorite